Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

CLVT

Clarivate (CLVT)

Clarivate PLC
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:CLVT
FechaHoraFuenteTítuloSímboloCompañía
24/07/202415:58Edgar (US Regulatory)Form 8-K - Current reportNYSE:CLVTClarivate PLC
24/07/202406:30PR Newswire (US)Clarivate Director Richard Roedel to Retire from Board of DirectorsNYSE:CLVTClarivate PLC
22/07/202405:00PR Newswire (US)Clarivate Acquires Rowan TELS to Enhance Support for Patent PractitionersNYSE:CLVTClarivate PLC
18/07/202402:00PR Newswire (US)Clarivate to Partner with OhioLINK and SearchOhio to Create a New Unified Library Experience Across the State of OhioNYSE:CLVTClarivate PLC
18/07/202402:00PR Newswire (US)BioWorld by Clarivate Celebrates Nine Wins at 2024 APEX AwardsNYSE:CLVTClarivate PLC
16/07/202408:00PR Newswire (US)Clarivate to Report Second Quarter 2024 Results on August 6, 2024NYSE:CLVTClarivate PLC
16/07/202402:00PR Newswire (US)Clarivate Annual G20 Scorecard Examines Global Research and Innovation Trends Across G20 MembersNYSE:CLVTClarivate PLC
10/07/202403:00PR Newswire (US)Clarivate Reveals First Year of Unitary Patent Court Litigation ActivityNYSE:CLVTClarivate PLC
02/07/202402:00PR Newswire (US)Clarivate Identifies Six Breakthrough MedTech Trends in 2024 Set to Unlock New Industry OpportunitiesNYSE:CLVTClarivate PLC
27/06/202405:15PR Newswire (US)Clarivate Report Demonstrates Societal Impact of Digital Health Research and Innovation GrowthNYSE:CLVTClarivate PLC
24/06/202402:00PR Newswire (US)Clarivate Launches IP Collaboration HubNYSE:CLVTClarivate PLC
20/06/202402:00PR Newswire (US)Clarivate Reveals World's Leading and Trusted Journals with the 2024 Journal Citation ReportsNYSE:CLVTClarivate PLC
19/06/202402:00PR Newswire (US)Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New Companies to Watch ReportNYSE:CLVTClarivate PLC
04/06/202402:00PR Newswire (US)Clarivate Launches Research Horizon Navigator to Pinpoint Future Breakthrough AreasNYSE:CLVTClarivate PLC
31/05/202402:00PR Newswire (US)Clarivate Expands Real-World Data Offering with Addition of Social Determinant of Health (SDoH) Attributes from HealthWise DataNYSE:CLVTClarivate PLC
30/05/202416:15PR Newswire (US)Clarivate Announces Conversion Date and Conversion Rate for Series A Mandatory Convertible Preferred SharesNYSE:CLVTClarivate PLC
30/05/202402:00PR Newswire (US)Clarivate Celebrates 500 Institutions Adopting Rialto Marketplace SolutionNYSE:CLVTClarivate PLC
29/05/202408:15PR Newswire (US)Clarivate to Present at Upcoming Investor Conferences in June 2024NYSE:CLVTClarivate PLC
22/05/202402:00PR Newswire (US)Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024NYSE:CLVTClarivate PLC
21/05/202402:00PR Newswire (US)New Clarivate Report Indicates Solid Growth in 2024 Global Trademark Filing ActivityNYSE:CLVTClarivate PLC
20/05/202402:00PR Newswire (US)Clarivate Launches AI-Enhanced Solution to Accelerate Trademark WatchingNYSE:CLVTClarivate PLC
17/05/202415:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:CLVTClarivate PLC
16/05/202402:00PR Newswire (US)New Clarivate Report Reveals that the U.S., Germany and Mainland China have the most Non-Practicing Entity LitigationNYSE:CLVTClarivate PLC
09/05/202402:00PR Newswire (US)OMRON Selects IPfolio from ClarivateNYSE:CLVTClarivate PLC
08/05/202415:37Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:CLVTClarivate PLC
08/05/202405:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:CLVTClarivate PLC
08/05/202405:00PR Newswire (US)Clarivate Reports First Quarter 2024 ResultsNYSE:CLVTClarivate PLC
07/05/202402:00PR Newswire (US)Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population AnalysisNYSE:CLVTClarivate PLC
02/05/202402:00PR Newswire (US)Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory SuccessNYSE:CLVTClarivate PLC
01/05/202415:05PR Newswire (US)Clarivate Declares Dividend on Mandatory Convertible Preferred SharesNYSE:CLVTClarivate PLC
 Showing the most relevant articles for your search:NYSE:CLVT